pargyline has been researched along with moclobemide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ercan, A; Jayaprakash, V; Sinha, BN; Ucar, G | 1 |
| Erol, K; Gökhan-Kelekçi, N; Kendi, E; Koyunoğlu, S; Ozgen, O; Uçar, G; Yabanoğlu, S; Yelekçi, K; Yeşilada, A | 1 |
| Byun, Y; Han, MH; Hong, SH; Jung, HI; Noh, M; Park, J; Park, S | 1 |
| Rényi, L | 1 |
| Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P | 1 |
| Alemany, R; García-Sevilla, JA; Olmos, G | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
7 other study(ies) available for pargyline and moclobemide
| Article | Year |
|---|---|
Pyrazoline-based mycobactin analogues as MAO-inhibitors.
Topics: Acetamides; Animals; Binding Sites; Catalytic Domain; Drug Design; Humans; Inhibitory Concentration 50; Linezolid; Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Pyrazoles; Rats; Siderophores | 2008 |
New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
Topics: Binding Sites; Flavin-Adenine Dinucleotide; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyrazoles; Quinazolinones | 2009 |
The opposite effect of isotype-selective monoamine oxidase inhibitors on adipogenesis in human bone marrow mesenchymal stem cells.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Antidiuretic Agents; Bone Marrow Cells; Humans; Mesenchymal Stem Cells; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenelzine; Tranylcypromine | 2013 |
The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5-methoxy-N,N-dimethyltryptamine in the rat.
Topics: Animals; Benzamides; Clorgyline; Dose-Response Relationship, Drug; Ejaculation; Male; Methoxydimethyltryptamines; Moclobemide; Monoamine Oxidase Inhibitors; Nialamide; p-Chloroamphetamine; Pargyline; Rats; Receptors, Serotonin; Selegiline; Serotonin; Time Factors | 1986 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior | 1987 |
The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Benzamides; Binding, Competitive; Brain; Chlorphenamidine; Clorgyline; Cytochrome P-450 Enzyme System; Dioxanes; Idazoxan; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Injections, Intraperitoneal; Isocarboxazid; Liver; Male; Moclobemide; Monoamine Oxidase Inhibitors; Pargyline; Phenelzine; Propylamines; Rats; Rats, Sprague-Dawley; Receptors, Drug; Tranylcypromine | 1995 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |